207 related articles for article (PubMed ID: 29970433)
1. Second-trimester Maternal Serum Screening Biomarkers in the Risk Assessment for Preeclampsia.
Long W; Zhou Q; Wang H; Lu B; Chen Y; Zhang B; Zhou W; Yu B
Ann Clin Lab Sci; 2018 May; 48(3):308-313. PubMed ID: 29970433
[TBL] [Abstract][Full Text] [Related]
2. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
3. [The value of maternal first and second trimester serum data of β-hCG, PAPP-A, AFP and uE3 in the prediction of preeclampsia].
Gu W; Lin J; Hou Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):101-7. PubMed ID: 25877605
[TBL] [Abstract][Full Text] [Related]
4. Multiple marker second trimester serum screening for pre-eclampsia.
Wald NJ; Morris JK
J Med Screen; 2001; 8(2):65-8. PubMed ID: 11480445
[TBL] [Abstract][Full Text] [Related]
5. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
[TBL] [Abstract][Full Text] [Related]
6. Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy.
Lambert-Messerlian GM; Silver HM; Petraglia F; Luisi S; Pezzani I; Maybruck WM; Hogge WA; Hanley-Yanez K; Roberts JM; Neveux LM; Canick JA
J Soc Gynecol Investig; 2000; 7(3):170-4. PubMed ID: 10865185
[TBL] [Abstract][Full Text] [Related]
7. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
[TBL] [Abstract][Full Text] [Related]
8. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
9. Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.
Räty R; Anttila L; Virtanen A; Koskinen P; Laitinen P; Mörsky P; Tiitinen A; Martikainen H; Ekblad U
Prenat Diagn; 2003 Dec; 23(13):1045-8. PubMed ID: 14691989
[TBL] [Abstract][Full Text] [Related]
10. Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia.
Olsen RN; Woelkers D; Dunsmoor-Su R; Lacoursiere DY
Am J Obstet Gynecol; 2012 Sep; 207(3):228.e1-7. PubMed ID: 22818876
[TBL] [Abstract][Full Text] [Related]
11. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
12. Association Analysis between Maternal Serum Biomarkers and Fetal Congenital Heart Disease.
Jiang H; Lin Y; He X
Heart Surg Forum; 2023 Oct; 26(5):E552-E559. PubMed ID: 37920073
[TBL] [Abstract][Full Text] [Related]
13. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry.
Audibert F; Benchimol Y; Benattar C; Champagne C; Frydman R
Fetal Diagn Ther; 2005; 20(1):48-53. PubMed ID: 15608460
[TBL] [Abstract][Full Text] [Related]
14. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels.
Räty R; Koskinen P; Alanen A; Irjala K; Matinlauri I; Ekblad U
Prenat Diagn; 1999 Feb; 19(2):122-7. PubMed ID: 10215068
[TBL] [Abstract][Full Text] [Related]
15. Relationship between increased maternal serum free human chorionic gonadotropin levels in the second trimester and adverse pregnancy outcomes: a retrospective cohort study.
Chen Y; Dai X; Wu B; Jiang C; Yin Y
BMC Womens Health; 2024 Jun; 24(1):323. PubMed ID: 38835013
[TBL] [Abstract][Full Text] [Related]
16. Population-based biomarker screening and the development of severe preeclampsia in California.
Taché V; Baer RJ; Currier RJ; Li CS; Towner D; Waetjen LE; Jelliffe-Pawlowski LL
Am J Obstet Gynecol; 2014 Oct; 211(4):377.e1-8. PubMed ID: 24631701
[TBL] [Abstract][Full Text] [Related]
17. [Predictive value analysis of Down's screening serological indicators in the second trimester for gestational hypertension].
Feng C; Liu XW; Wang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Jun; 55(6):747-751. PubMed ID: 34139815
[No Abstract] [Full Text] [Related]
18. Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters.
Zhang J; Lambert-Messerlian G; Palomaki GE; Canick JA
Prenat Diagn; 2011 Jun; 31(6):583-8. PubMed ID: 21480302
[TBL] [Abstract][Full Text] [Related]
19. Maternal Serum PLGF, PAPPA, β-hCG and AFP Levels in Early Second Trimester as Predictors of Preeclampsia.
Duan H; Zhao G; Xu B; Hu S; Li J
Clin Lab; 2017 May; 63(5):921-925. PubMed ID: 28627818
[TBL] [Abstract][Full Text] [Related]
20. Association of low unconjugated estriol in the second trimester and adverse pregnancy outcome.
Kowalczyk TD; Cabaniss ML; Cusmano L
Obstet Gynecol; 1998 Mar; 91(3):396-400. PubMed ID: 9491867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]